About Isolere Bio
Isolere Bio is a company based in Durham (United States) founded in 2017 by Joseph McMahon, Ashutosh Chilkoti, and Kelli Luginbuhl was acquired by Donaldson Company in February 2023.. Isolere Bio has raised $7 million across 7 funding rounds from investors including Donaldson Company, HHS and NCBiotech. Isolere Bio offers products and services including IsoTag™ AAV and IsoTag™ LV. Isolere Bio operates in a competitive market with competitors including ExBiome, REV-MED, Zepteon, VIRAPUR and Norgen Biotek, among others.
- Headquarter Durham, United States
- Founders Joseph McMahon, Ashutosh Chilkoti, Kelli Luginbuhl
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Isolere Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7 M (USD)
in 7 rounds
-
Latest Funding Round
$255.56 K (USD), Grant
Feb 01, 2022
-
Investors
Donaldson Company
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Donaldson Company
(Feb 21, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Isolere Bio
Isolere Bio offers a comprehensive portfolio of products and services, including IsoTag™ AAV and IsoTag™ LV. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reagent for high-yield AAV purification without chromatography.
Reagent for efficient lentiviral vector purification processes.
Unlock access to complete
Unlock access to complete
Funding Insights of Isolere Bio
Isolere Bio has successfully raised a total of $7M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $255.56 thousand completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $255,556
-
First Round
First Round
(01 Aug 2018)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Grant - Isolere Bio | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - Isolere Bio | Valuation |
investors |
|
| May, 2021 | Amount | Seed - Isolere Bio | Valuation | Northpond Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Isolere Bio
Isolere Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Donaldson Company, HHS and NCBiotech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
Biotech startups are incubated and funded in North Carolina.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Isolere Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Isolere Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Isolere Bio Comparisons
Competitors of Isolere Bio
Isolere Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ExBiome, REV-MED, Zepteon, VIRAPUR and Norgen Biotek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops innovative diagnostic technologies for cancer detection from blood samples.
|
|
| domain | founded_year | HQ Location |
Limited details on core medical activities are available.
|
|
| domain | founded_year | HQ Location |
Biomolecular separation tools for antibody potency evaluation are developed.
|
|
| domain | founded_year | HQ Location |
Provides viral reagents and assay services for scientific and medical research.
|
|
| domain | founded_year | HQ Location |
Offers kits and services for RNA, DNA extraction, purification, and genomics research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Isolere Bio
Frequently Asked Questions about Isolere Bio
When was Isolere Bio founded?
Isolere Bio was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Isolere Bio located?
Isolere Bio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of Isolere Bio?
Kelli Luginbuhl is the current CEO of Isolere Bio. They have also founded this company.
Is Isolere Bio a funded company?
Isolere Bio is a funded company, having raised a total of $7M across 7 funding rounds to date. The company's 1st funding round was a Seed of $7M, raised on Aug 01, 2018.
What does Isolere Bio do?
Isolere Bio was founded in 2017 and is located in Durham, United States. A platform for the purification of biotherapeutics is offered, centered on tangential flow filtration (TFF) technology. Antibodies and adeno-associated viruses are developed and manufactured through this simplified TFF method within the biotechnology sector. Operations support the creation of new drugs and diagnostics by streamlining purification processes for biopharmaceutical applications.
Who are the top competitors of Isolere Bio?
What products or services does Isolere Bio offer?
Isolere Bio offers IsoTag™ AAV and IsoTag™ LV.
Who are Isolere Bio's investors?
Isolere Bio has 5 investors. Key investors include Donaldson Company, HHS, NCBiotech, Northpond Ventures, and America’s Seed Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.